Lipid nanoparticles carry gene-editing cancer drugs past tumor defenses

Cancer survivors grew to 18 million in the US; more than two-thirds aged 65 years or older

Clinical trial shows improved rare blood cancer treatment

Blood test developed to predict liver cancer risk